Medicare Enrolled
Dr. Jose Lira, M.D.
Pulmonary Disease · Chula Vista, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lira from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lira?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lira
Dr. Jose Lira is a pulmonary disease specialist in Chula Vista, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lira performed 1,751 Medicare services across 863 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lira received a total of $20,275 from 68 pharmaceutical and/or device companies across 1061 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lira is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 22% volume in CA
$20,275 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,751
Medicare services
Top 22% in CA for pulmonary disease
863
Unique beneficiaries
$86
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~88 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,302 | $97 | $142 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
72 | $49 | $109 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
50 | $124 | $180 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
39 | $35 | $99 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
39 | $39 | $60 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
39 | $52 | $80 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
38 | $30 | $31 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
38 | $31 | $32 |
| Pneumococcal vaccine, 23-valent A vaccine that protects against 23 types of pneumococcal bacteria. It is used to prevent infections caused by these bacteria. |
33 | $131 | $135 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
32 | $32 | $34 |
| Inhaled albuterol and ipratropium bromide via DME Administration of FDA-approved albuterol and ipratropium bromide medication through durable medical equipment. |
25 | $0 | $19 |
| Inhalation treatment for airway obstruction or sputum production A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production. |
24 | $8 | $19 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
20 | $91 | $150 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$20,275
Total received (2018-2024)
Avg $2,896/year across 7 years
Top 9% in CA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
1,061
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,168 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$106 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,044
2023
$3,582
2022
$3,285
2021
$3,106
2020
$2,054
2019
$2,252
2018
$2,952
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$546
GlaxoSmithKline, LLC.
$524
Boehringer Ingelheim Pharmaceuticals, Inc.
$220
Grifols USA, LLC
$179
Medtronic, Inc.
$170
HARMONY BIOSCIENCES LLC
$155
Insmed, Inc.
$154
Regeneron Healthcare Solutions, Inc.
$119
GENZYME CORPORATION
$115
Inspire Medical Systems, Inc.
$99
Mylan Specialty L.P.
$76
Noctrix Health, Inc.
$73
Avadel CNS Pharmaceuticals, LLC
$66
JAZZ PHARMACEUTICALS INC.
$58
United Therapeutics Corporation
$55
Novartis Pharmaceuticals Corporation
$48
Novo Nordisk Inc
$46
Harmony Biosciences Llc
$45
Actelion Pharmaceuticals US, Inc.
$41
Fisher & Paykel Healthcare Inc
$36
Merck Sharp & Dohme LLC
$30
Amgen Inc.
$28
ABBVIE INC.
$27
Genentech USA, Inc.
$25
Edwards Lifesciences Corporation
$25
Philips North America LLC
$22
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$22
Takeda Pharmaceuticals U.S.A., Inc.
$21
Axsome Therapeutics, Inc.
$19
Top 3 companies account for 42.4% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$3,953
GlaxoSmithKline, LLC.
$3,532
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,608
Grifols USA, LLC
$1,126
Philips Electronics North America Corporation
$802
Genentech USA, Inc.
$600
Insmed, Inc.
$575
Harmony Biosciences LLC
$556
Sunovion Pharmaceuticals Inc.
$370
JAZZ PHARMACEUTICALS INC.
$359
Regeneron Healthcare Solutions, Inc.
$359
Takeda Pharmaceuticals U.S.A., Inc.
$341
Medtronic, Inc.
$293
Janssen Pharmaceuticals, Inc
$282
Mylan Specialty L.P.
$251
GENZYME CORPORATION
$237
PFIZER INC.
$231
Novo Nordisk Inc
$216
Merck Sharp & Dohme LLC
$205
Merck Sharp & Dohme Corporation
$204
HARMONY BIOSCIENCES LLC
$182
Lilly USA, LLC
$166
United Therapeutics Corporation
$151
Novartis Pharmaceuticals Corporation
$149
Actelion Pharmaceuticals US, Inc.
$137
Paratek Pharmaceuticals, Inc.
$133
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$132
Intuitive Surgical, Inc.
$128
Inspire Medical Systems, Inc.
$128
SANOFI-AVENTIS U.S. LLC
$124
Advanced Respiratory, Inc
$122
Electromed, Inc.
$111
Jazz Pharmaceuticals Inc.
$110
Amgen Inc.
$98
Baxter Healthcare
$91
Avadel CNS Pharmaceuticals, LLC
$89
ABBVIE INC.
$76
Gilead Sciences, Inc.
$75
Noctrix Health, Inc.
$73
E.R. Squibb & Sons, L.L.C.
$69
La Jolla Pharmaceutical Company
$64
Axsome Therapeutics, Inc.
$55
Fisher & Paykel Healthcare Inc
$53
Phadia US Inc.
$52
Harmony Biosciences Llc
$45
Boston Scientific Corporation
$40
IDORSIA PHARMACEUTICALS US INC
$36
Teva Pharmaceuticals USA, Inc.
$35
Esperion Therapeutics, Inc.
$32
Bayer Healthcare Pharmaceuticals Inc.
$32
Daiichi Sankyo Inc.
$32
AbbVie Inc.
$31
Mallinckrodt Hospital Products Inc.
$28
ADVANCED RESPIRATORY, INC
$27
Shire North American Group Inc
$26
Resmed Corp
$26
Edwards Lifesciences Corporation
$25
AbbVie, Inc.
$24
Philips North America LLC
$22
Bayer HealthCare Pharmaceuticals Inc.
$22
Vertiflex, Inc.
$19
Inogen, Inc.
$18
Tactile Systems Technology Inc
$17
Seqirus USA Inc
$15
Azurity Pharmaceuticals, Inc.
$15
Medtronic Vascular, Inc.
$14
Abbott Laboratories
$14
SANOFI PASTEUR INC.
$12
Top 3 companies account for 49.8% of all-time payments
Associated products mentioned in payments ›
(2446) PRI Cpap Auto Core · (7999) SRC Und · (8874) inCourage · (9061) SRC Sol Space · (O58) Sleep Respiratory Care Und · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · AirDuo Digihaler · AirFit · Amitiza · Arikayce · Azure · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHANTIX · CINQAIR · CUTAQUIG · Cathflo Activase · DIFICID · DUPIXENT · Da Vinci Surgical System · DreamStat Cpap Auto · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · EMGALITY · ENTRESTO · EVUSHELD · Esbriet · FARXIGA · FASENRA · FISHER & PAYKEL HEALTHCARE · FLUBLOK QUADRIVALENT · Flexitouch Plus · Fluad Quadrivalent · GIAPREZA · GLASSIA · Hillrom - Life 2000 Ventilation System · Horizant · INJECTAFER · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · Kerendia · LONHALA MAGNAIR · LUMRYZ · Life 2000 Ventilation System · MICRA · MOUNJARO · Mitra Clip system · NEXLETOL · NIDRA · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · Otezla · Ozempic · PRADAXA · PRALUENT · PRI Cpap Auto · PRI Cpap Auto Core · Prolastin-C · Prolastin-C Liquid · QUVIVIQ · RYBELSUS · Repatha · Respiratoriy Care Undiv · SHINGRIX · SMARTVEST · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · Superion ISS · TAVNEOS · TEZSPIRE · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · TYVASO · The Vest System Model 105 Home Care · Tresiba · Trilogy 100 · UBRELVY · UPTRAVI · Utibron · VERQUVO · VRAYLAR · Victoza · Volara System · WAKIX · WATCHMAN · WATCHMAN FLX · WINREVAIR · Wakix · Wellcentive Undiv · XARELTO · XIFAXAN · XOLAIR · XYREM · XYWAV · Xofluza · Xolair · Xyrem · YUPELRI · Yupelri · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for pulmonary disease in CA.
Geographic Context
Pulmonary diseases within 10 mi
108
Per 100K population
3.3
County median income
$102,285
Nearest hospital
SHARP CHULA VISTA MEDICAL CENTER
6.9 mi
6.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lira is a clinical cardiology specialist, with above-average Medicare volume (top 22% in CA), with low-engagement industry engagement in the top 9% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lira experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Lira performed 1,302 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lira receive payments from pharmaceutical companies?
Yes. Dr. Lira received a total of $20,275 from 68 companies across 1,061 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lira's costs compare to other pulmonary diseases in Chula Vista?
Dr. Lira's average Medicare payment per service is $86. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lira) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Chula Vista
Browse pulmonary diseases in Chula Vista ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in CA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in CA
Which CA pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology